Back
Arcutis Biotherapeutics Stock Price Chart
Sponsored
ARQT
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.38
Seasonality Move:
-24.31%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
Arcutis Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.59 | Sell |
20-day SMA: | 10.15 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.07 | Buy |
8-day EMA: | 10.49 | Sell |
20-day EMA: | 10.26 | Sell |
50-day EMA: | 9.87 | Buy |
200-day EMA: | 8.92 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 50.27 | Buy |
Chaikin Money Flow: | -1021551 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.03 - 10.89) | Buy |
Bollinger Bands (100): | (8.3 - 10.24) | Buy |
Arcutis Biotherapeutics Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.16 while ARQT 8-day simple moving average is 10.59, which is a Sell signal.
- The stock price of ARQT is 10.16 while Arcutis Biotherapeutics 20-day SMA is 10.15, which makes it a Buy.
- Arcutis Biotherapeutics 50-day simple moving average is 9.91 while ARQT share price is 10.16, making it a Buy technically.
- ARQT stock price is 10.16 and Arcutis Biotherapeutics 200-day simple moving average is 8.07, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Sell
The current Arcutis Biotherapeutics [ARQT] share price is $10.16. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.19B
Price in USD:
10.16
Share Volume:
1.44M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 10.16 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.16 while ARQT 8-day exponential moving average is 10.49, which is a Sell signal.
- The stock price of ARQT is 10.16 while Arcutis Biotherapeutics 20-day EMA is 10.26, which makes it a Sell.
- Arcutis Biotherapeutics 50-day exponential moving average is 9.87 while ARQT share price is 10.16, making it a Buy technically.
- ARQT stock price is 10.16 and Arcutis Biotherapeutics 200-day simple moving average is 8.92, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 50.27, which suggest Arcutis Biotherapeutics is overbought
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (9.03 - 10.89), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.3 - 10.24), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.